DTL
FDMT icon

Dynamic Technology Lab’s 4D Molecular Therapeutics FDMT Stock Holding History

Dynamic Technology Lab’s Portfolio FDMT Stock Details FDMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-16,369
Closed -$61K – 950
2025
Q2 		$61K Buy
16,369
+4,295
+36% +$15.1K 0.01% 864
2025
Q1 		$39K Buy
+12,074
New +$56.9K 0.01% 938
2023
Q4 		– Sell
-26,330
Closed -$335K – 1148
2023
Q3 		$335K Buy
+26,330
New +$440K 0.03% 615
2022
Q4 		– Sell
-17,023
Closed -$137K – 1229
2022
Q3 		$137K Buy
+17,023
New +$154K 0.01% 995

Other funds holding FDMT

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Dynamic Technology Lab's FDMT Position: Q3 2025 in Review

Dynamic Technology Lab sold out of 4D Molecular Therapeutics (FDMT) in Q3 2025, closing a stake of 16,369 shares — an estimated $61K sold.

Dynamic Technology Lab first reported a position in FDMT in Q3 2022 and held it in 4 quarters. The position peaked at $335K in Q3 2023. 134 funds tracked by Wall St. Rank hold FDMT as of Q3 2025.

  • Dynamic Technology Lab reported no remaining 4D Molecular Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Dynamic Technology Lab sold 16,369 4D Molecular Therapeutics shares in Q3 2025, an estimated $61K.
  • Dynamic Technology Lab first reported a position in 4D Molecular Therapeutics in Q3 2022 and held it in 4 quarters.
  • Dynamic Technology Lab's 4D Molecular Therapeutics position peaked at $335K in Q3 2023.
  • 134 funds tracked by Wall St. Rank held 4D Molecular Therapeutics as of Q3 2025.

Based on Dynamic Technology Lab's 13F filing for Q3 2025, filed 13 Nov 2025.